Mutations in BRCA1 do not appear to contribute significantly to the risk of prostate cancer progression, according to DNA ...
40m
Hosted on MSNFormer Top Drug Regulator Lands Cushy Pfizer Gig After Leaving FDA During Trump TransitionPatrizia Cavazzoni, the former director of the Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results